Maroney Dawn Christine sold $1.6M of ALHC

Maroney Dawn Christine (President) sold 122,707 shares of Alignment Healthcare, Inc. (ALHC) at $12.68 ($1.56M total) on 2026-09-11.

Original reporting
SEC EDGAR · Maroney Dawn Christine
Published Sep 12, 2026, 12:41 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 1:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALHC
Neutral
medium confidence
Mentioned
$ALHC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALHCNeutralLow
01

Why it matters

The sale reduces insider ownership but is not large enough to trigger significant price movement.

02

Market read

Routine insider sale with modest size; limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 6/10Novelty 4/10Timing: filing date 2026-09-11

Background

Form 4 filing reports insider transactions; investors monitor for signals.

Company-level read

Ticker impact

$ALHCNeutralMedium confidence
Context

President Maroney Dawn Christine sold 122,707 shares for $1.56M, reducing her stake to 794,606 shares.

Expected impact

Potential slight downward pressure in short term.

Evidence & confidence

Sale amount is under 2% of total shares; market may view as routine.

Market effects

Minimal impact on healthcare sector.

None.

None.

Counterpoint

Insider may be diversifying; sale does not imply negative outlook.

Key entities

  • Alignment Healthcare, Inc.

    US-listed healthcare company (ticker ALHC).

  • Maroney Dawn Christine

    President of Alignment Healthcare.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.